Similarly, while the inhibition of SUCNR1 has been proposed as a strategy to alleviate various inflammatory conditions [4], its blockade might be detrimental in treating inflammation and glucose intolerance in obesity [27]. This evidence concerns the gene SUCNR1 and obesity due to melanocortin 4 receptor deficiency.